Friday, 17 Aug 2018

You are here

Sons of Gout Study

The genetics and heritability of gout has suggested a higher risk in certain families.  A UK cohort study examined the prevalence of gout and monosodium urate (MSU) crystal deposition among those at risk (sons of gout patients) for gout and found a high incidence of hyperuricemia and MSU crystal deposition.

The sons of patients with gout (n=131) were contacted, screened by telephone and subsequently had a study-visit evaluation for blood and urine collection, and musculoskeletal ultrasonography (MSK US).

Amongst 131 sons of gout, 64.1% had serum urate (SU) ≥6 mg/dl, and 30% had MSK US evidence of either a double contour sign (DCS) or intra-articular aggregates/tophi in ≥1 joint.

All subjects with MSU deposition had involvement of 1st metatarsophalangeal joint and a subset (21%) had intra-tendinous aggregates.

For those with SU ≤5 mg/dl no MSU depositoin was found; but those 24% of those with SU between 5-6 mg/dl had ultrasonographic MSU deposition.

For every SU increased of 1 mg/dl, there was a 61% increase in the odds of finding MSU crystal deposition.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Selective Use of HLA-B*5801 Testing in Gout

The current edition of JAMA Internal Medicine describes an Asian gout patient who presents with an allopurinol hypersensitivity reaction that could have been diagnosed by testing for HLA-B*5801.

Febuxostat (IR or XR) Effective in Gout with Renal Impairment

Saag and colleagues report the results of a 3 month phase III trial demonstrating equal efficacy between febuxostat extended release (XR) and immediate release (IR) formulations in patients with gout.  and normal or impaired renal function.

Steroids vs. NSAIDs in Treating Acute Gout

Gout, the ancient disease of kings is usually treated with the ancient (and costly) drug colchicine, often without consideration of nonsteroidal antiinflammatory drugs (NSAID) or corticosteroids. A recent metanalysis compared the NSAIDS and steroids and showed that both were equipotent in managing the pain of acute gout, but corticosteroids appear had a more favorable safety profile. 

Erectile Dysfunction in Gout

The Journal of Rheumatology reports a population-based study demonstrating that gout is associated with an increased risk of developing erectile dysfunction (ED) suggesting that hyperuricemia and inflammation may be independent risk factors for ED.

Immunophysiology of the Gout Attack

Gout may be an ancient disease, with arthritis of the big toe having been described in Egypt in 2,600 BC, but only now are the underlying pathophysiologic events being elucidated and understood.